Back to Journals » Clinical Ophthalmology » Volume 6

Effect of photodynamic therapy (PDT), posterior subtenon injection of triamcinolone acetonide with PDT, and intravitreal injection of ranibizumab with PDT for retinal angiomatous proliferation

Authors Nakano, Honda S, Ou H, Kita M, Akira Negi

Received 5 January 2012

Accepted for publication 13 January 2012

Published 20 February 2012 Volume 2012:6 Pages 277—282

DOI https://doi.org/10.2147/OPTH.S29718

Review by Single-blind

Peer reviewer comments 2


Saya Nakano1, Shigeru Honda1, Hideyasu Oh2, Mihori Kita2, Akira Negi1

1Department of Surgery, Division of Ophthalmology, Kobe University Graduate School of Medicine, Kobe, 2Department of Ophthalmology, Hyogo Prefectural Amagasaki Hospital, Amagasaki, Japan

Background: The purpose of this work was to compare the efficacy of photodynamic therapy (PDT) with or without posterior subtenon injections of triamcinolone acetonide (STA) or intravitreal injections of ranibizumab (IVR) for retinal angiomatous proliferation (RAP).
Methods: Thirty-seven eyes from 33 consecutive patients with RAP were treated by PDT monotherapy (Group 1), PDT combined with STA (Group 2), or PDT combined with IVR (Group 3). The best-corrected visual acuity, greatest linear dimension, central retinal thickness, and number of treatments were compared among the three groups.
Results: The change in mean best-corrected visual acuity (logMAR) at month 3, 6, and 12 after the initial treatment was better in Group 2 (-0.13, -0.23, and -0.21, respectively) and Group 3 (-0.018, 0.0028, and -0.0067, respectively) than in Group 1 (0.13, 0.19, and 0.23, respectively); Group 1 versus Group 2 was statistically significant (P = 0.018). The mean central retinal thickness was reduced from baseline in all groups, but the reduction amplitude was significantly greater in Group 2 than in Group 1 and Group 3. The mean number of treatments was significantly lower in Group 2 (1.1 ± 0.4) and Group 3 (1.5 ± 0.5) than in Group 1 (2.9 ± 0.9) in the 12 months after the initial treatment.
Conclusion: Treatment with STA + PDT may be an effective therapy for RAP lesions over 12 months of follow-up.

Keywords: retinal angiomatous proliferation, photodynamic therapy, triamcinolone acetonide, ranibizumab, combined therapy

Creative Commons License This work is published and licensed by Dove Medical Press Limited. The full terms of this license are available at https://www.dovepress.com/terms.php and incorporate the Creative Commons Attribution - Non Commercial (unported, v3.0) License. By accessing the work you hereby accept the Terms. Non-commercial uses of the work are permitted without any further permission from Dove Medical Press Limited, provided the work is properly attributed. For permission for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms.

Download Article [PDF]  View Full Text [HTML][Machine readable]